{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2007-D-0369\" and posted_year = 2026 sorted by posted_date descending", "rows": [["FDA-2007-D-0369-2444", "FDA", "FDA-2007-D-0369", "PSG_020151 - Draft Guidance on Venlafaxine Hydrochloride", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:22:37Z", null, 1, 0, "09000064b91df4e6"], ["FDA-2007-D-0369-2442", "FDA", "FDA-2007-D-0369", "PSG_020144 - Draft Guidance on Nitroglycerin", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:21:57Z", null, 1, 0, "09000064b91df4d8"], ["FDA-2007-D-0369-2432", "FDA", "FDA-2007-D-0369", "PSG_018084 - Draft Guidance on Tolmetin Sodium", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:18:51Z", null, 1, 0, "09000064b91df465"], ["FDA-2007-D-0369-2457", "FDA", "FDA-2007-D-0369", "PSG_021336 - Draft Guidance on Selegiline", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:26:39Z", null, 1, 0, "09000064b91e011b"], ["FDA-2007-D-0369-2440", "FDA", "FDA-2007-D-0369", "PSG_019982 - Draft Guidance on Bisoprolol Fumarate", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:21:21Z", null, 1, 0, "09000064b91df4d4"], ["FDA-2007-D-0369-2447", "FDA", "FDA-2007-D-0369", "PSG_020375 - Draft Guidance on Estradiol", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:23:38Z", null, 1, 0, "09000064b91df4f2"], ["FDA-2007-D-0369-2459", "FDA", "FDA-2007-D-0369", "PSG_021427 - Draft Guidance on Duloxetine Hydrochloride", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:27:37Z", null, 1, 0, "09000064b91e011f"], ["FDA-2007-D-0369-2461", "FDA", "FDA-2007-D-0369", "PSG_021514 - Draft Guidance on Methylphenidate", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:29:28Z", null, 1, 0, "09000064b91e0123"], ["FDA-2007-D-0369-2438", "FDA", "FDA-2007-D-0369", "PSG_019813 - Draft Guidance on Fentanyl", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:20:47Z", null, 1, 0, "09000064b91df4d0"], ["FDA-2007-D-0369-2464", "FDA", "FDA-2007-D-0369", "PSG_021829 - Draft Guidance on Rotigotine", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:30:54Z", null, 1, 0, "09000064b91e0129"], ["FDA-2007-D-0369-2497", "FDA", "FDA-2007-D-0369", "PSG_213224 - Draft Guidance on Octreotide acetate", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:42:17Z", null, 1, 0, "09000064b91e018a"], ["FDA-2007-D-0369-2490", "FDA", "FDA-2007-D-0369", "PSG_211843 - Draft Guidance on Tiopronin", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:39:55Z", null, 1, 0, "09000064b91e0172"], ["FDA-2007-D-0369-2475", "FDA", "FDA-2007-D-0369", "PSG_202211 - Draft Guidance on Oxybutynin", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:35:11Z", null, 1, 0, "09000064b91e0140"], ["FDA-2007-D-0369-2466", "FDA", "FDA-2007-D-0369", "PSG_022029 - Draft Guidance on Menthol; Methyl Salicylate", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:31:54Z", null, 1, 0, "09000064b91e012d"], ["FDA-2007-D-0369-2467", "FDA", "FDA-2007-D-0369", "PSG_022083 - Draft Guidance on Rivastigmine", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:32:28Z", null, 1, 0, "09000064b91e012f"], ["FDA-2007-D-0369-2520", "FDA", "FDA-2007-D-0369", "PSG_218466 - Draft Guidance on Alpelisib", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:50:12Z", null, 1, 0, "09000064b91e01d3"], ["FDA-2007-D-0369-2511", "FDA", "FDA-2007-D-0369", "PSG_216352 - Draft Guidance on Paliperidone Palmitate", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:47:03Z", null, 1, 0, "09000064b91e01b4"], ["FDA-2007-D-0369-2512", "FDA", "FDA-2007-D-0369", "PSG_216665 - Draft Guidance on Diazoxide Choline", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:47:20Z", null, 1, 0, "09000064b91e01b6"], ["FDA-2007-D-0369-2508", "FDA", "FDA-2007-D-0369", "PSG_215431 - Draft Guidance on Meloxicam; Rizatriptan Benzoate", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:46:07Z", null, 1, 0, "09000064b91e01ad"], ["FDA-2007-D-0369-2481", "FDA", "FDA-2007-D-0369", "PSG_207620 - Draft Guidance on Sacubitril; Valsartan", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:37:17Z", null, 1, 0, "09000064b91e0156"], ["FDA-2007-D-0369-2489", "FDA", "FDA-2007-D-0369", "PSG_211733 - Draft Guidance on Acetaminophen; Ibuprofen", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:39:39Z", null, 1, 0, "09000064b91e0170"], ["FDA-2007-D-0369-2479", "FDA", "FDA-2007-D-0369", "PSG_206089 - Draft Guidance on Testosterone Undecanoate", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:36:31Z", null, 1, 0, "09000064b91e0152"], ["FDA-2007-D-0369-2469", "FDA", "FDA-2007-D-0369", "PSG_022264 - Draft Guidance on Paliperidone Palmitate", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:33:09Z", null, 1, 0, "09000064b91e0133"], ["FDA-2007-D-0369-2473", "FDA", "FDA-2007-D-0369", "PSG_085635 - Draft Guidance on Testosterone Cypionate", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:34:27Z", null, 1, 0, "09000064b91e013c"], ["FDA-2007-D-0369-2488", "FDA", "FDA-2007-D-0369", "PSG_210868 - Draft Guidance on Lorlatinib", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:39:21Z", null, 1, 0, "09000064b91e016e"], ["FDA-2007-D-0369-2486", "FDA", "FDA-2007-D-0369", "PSG_209310 - Draft Guidance on Mometasone Furoate", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:38:46Z", null, 1, 0, "09000064b91e016a"], ["FDA-2007-D-0369-2506", "FDA", "FDA-2007-D-0369", "PSG_215401 - Draft Guidance on Dextroamphetamine", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:45:23Z", null, 1, 0, "09000064b91e01a9"], ["FDA-2007-D-0369-2522", "FDA", "FDA-2007-D-0369", "PSG_218585 - Draft Guidance on Aceclidine Hydrochloride", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:51:02Z", null, 1, 0, "09000064b91e01d7"], ["FDA-2007-D-0369-2509", "FDA", "FDA-2007-D-0369", "PSG_215602 - Draft Guidance on Baclofen", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:46:21Z", null, 1, 0, "09000064b91e01af"], ["FDA-2007-D-0369-2516", "FDA", "FDA-2007-D-0369", "PSG_217225 - Draft Guidance on Avacincaptad Pegol Sodium", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:48:56Z", null, 1, 0, "09000064b91e01cb"], ["FDA-2007-D-0369-2507", "FDA", "FDA-2007-D-0369", "PSG_215429 - Draft Guidance on Venlafaxine Besylate", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:45:49Z", null, 1, 0, "09000064b91e01ab"], ["FDA-2007-D-0369-2443", "FDA", "FDA-2007-D-0369", "PSG_020145 - Draft Guidance on Nitroglycerin", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:22:16Z", null, 1, 0, "09000064b91df4da"], ["FDA-2007-D-0369-2460", "FDA", "FDA-2007-D-0369", "PSG_021447 - Draft Guidance on Tizanidine Hydrochloride", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:27:59Z", null, 1, 0, "09000064b91e0121"], ["FDA-2007-D-0369-2446", "FDA", "FDA-2007-D-0369", "PSG_020357 - Draft Guidance on Metformin Hydrochloride", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:23:14Z", null, 1, 0, "09000064b91df4f0"], ["FDA-2007-D-0369-2429", "FDA", "FDA-2007-D-0369", "PSG_012283 - Draft Guidance on Chlorthalidone", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:17:46Z", null, 1, 0, "09000064b91df45f"], ["FDA-2007-D-0369-2441", "FDA", "FDA-2007-D-0369", "PSG_020076 - Draft Guidance on Nicotine", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:21:38Z", null, 1, 0, "09000064b91df4d6"], ["FDA-2007-D-0369-2435", "FDA", "FDA-2007-D-0369", "PSG_018891 - Draft Guidance on Clonidine", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:19:51Z", null, 1, 0, "09000064b91df4ca"], ["FDA-2007-D-0369-2453", "FDA", "FDA-2007-D-0369", "PSG_021180 - Draft Guidance on Ethinyl Estradiol; Norelgestromin", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:25:18Z", null, 1, 0, "09000064b91e0108"], ["FDA-2007-D-0369-2439", "FDA", "FDA-2007-D-0369", "PSG_019927 - Draft Guidance on Ketoconazole", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:21:03Z", null, 1, 0, "09000064b91df4d2"], ["FDA-2007-D-0369-2448", "FDA", "FDA-2007-D-0369", "PSG_020489 - Draft Guidance on Testosterone", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:23:57Z", null, 1, 0, "09000064b91df4f4"], ["FDA-2007-D-0369-2454", "FDA", "FDA-2007-D-0369", "PSG_021234 - Draft Guidance on Diclofenac Epolamine", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:25:35Z", null, 1, 0, "09000064b91e010a"], ["FDA-2007-D-0369-2500", "FDA", "FDA-2007-D-0369", "PSG_214410 - Draft Guidance on Baloxavir Marboxil", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:43:31Z", null, 1, 0, "09000064b91e0190"], ["FDA-2007-D-0369-2494", "FDA", "FDA-2007-D-0369", "PSG_212516 - Draft Guidance on Duloxetine Hydrochloride", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:41:20Z", null, 1, 0, "09000064b91e0184"], ["FDA-2007-D-0369-2484", "FDA", "FDA-2007-D-0369", "PSG_208143 - Draft Guidance on Barium Sulfate", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:38:13Z", null, 1, 0, "09000064b91e015c"], ["FDA-2007-D-0369-2495", "FDA", "FDA-2007-D-0369", "PSG_212526 - Draft Guidance on Alpelisib", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:41:39Z", null, 1, 0, "09000064b91e0186"], ["FDA-2007-D-0369-2476", "FDA", "FDA-2007-D-0369", "PSG_203479 - Draft Guidance on Clozapine", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:35:30Z", null, 1, 0, "09000064b91e014c"], ["FDA-2007-D-0369-2482", "FDA", "FDA-2007-D-0369", "PSG_207962 - Draft Guidance on Lidocaine", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:37:34Z", null, 1, 0, "09000064b91e0158"], ["FDA-2007-D-0369-2523", "FDA", "FDA-2007-D-0369", "PSG_219016 - Draft Guidance on Rilpivirine Hydrochloride", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:51:25Z", null, 1, 0, "09000064b91e01d9"], ["FDA-2007-D-0369-2514", "FDA", "FDA-2007-D-0369", "PSG_216962 - Draft Guidance on Foscarbidopa; Foslevodopa", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:48:20Z", null, 1, 0, "09000064b91e01ba"], ["FDA-2007-D-0369-2517", "FDA", "FDA-2007-D-0369", "PSG_217370 - Draft Guidance on Acoltremon", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:49:14Z", null, 1, 0, "09000064b91e01cd"], ["FDA-2007-D-0369-2515", "FDA", "FDA-2007-D-0369", "PSG_217202 - Draft Guidance on Landiolol Hydrochloride", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:48:39Z", null, 1, 0, "09000064b91e01bc"], ["FDA-2007-D-0369-2480", "FDA", "FDA-2007-D-0369", "PSG_206968 - Draft Guidance on Acetaminophen", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:36:59Z", null, 1, 0, "09000064b91e0154"], ["FDA-2007-D-0369-2428", "FDA", "FDA-2007-D-0369", "Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability", "Notice", "Notice of Availability", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", null, "2026-02-27T19:14:17Z", "2026-03963", 0, 0, "09000064b91e3271"], ["FDA-2007-D-0369-2456", "FDA", "FDA-2007-D-0369", "PSG_021306 - Draft Guidance on Buprenorphine", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:26:18Z", null, 1, 0, "09000064b91e0119"], ["FDA-2007-D-0369-2492", "FDA", "FDA-2007-D-0369", "PSG_212304 - Draft Guidance on Donepezil Hydrochloride", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:40:33Z", null, 1, 0, "09000064b91e0180"], ["FDA-2007-D-0369-2503", "FDA", "FDA-2007-D-0369", "PSG_215039 - Draft Guidance on Alpelisib", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:44:36Z", null, 1, 0, "09000064b91e0196"], ["FDA-2007-D-0369-2493", "FDA", "FDA-2007-D-0369", "PSG_212306 - Draft Guidance on Selinexor", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:40:55Z", null, 1, 0, "09000064b91e0182"], ["FDA-2007-D-0369-2498", "FDA", "FDA-2007-D-0369", "PSG_213953 - Draft Guidance on Testosterone Undecanoate", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:42:31Z", null, 1, 0, "09000064b91e018c"], ["FDA-2007-D-0369-2472", "FDA", "FDA-2007-D-0369", "PSG_050440 - Draft Guidance on Cephalexin", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:34:04Z", null, 1, 0, "09000064b91e013a"], ["FDA-2007-D-0369-2485", "FDA", "FDA-2007-D-0369", "PSG_208171 - Draft Guidance on Ferric Derisomaltose", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:38:28Z", null, 1, 0, "09000064b91e015e"], ["FDA-2007-D-0369-2501", "FDA", "FDA-2007-D-0369", "PSG_214522 - Draft Guidance on Tadalafil", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:44:01Z", null, 1, 0, "09000064b91e0192"], ["FDA-2007-D-0369-2491", "FDA", "FDA-2007-D-0369", "PSG_212268 - Draft Guidance on Asenapine", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:40:16Z", null, 1, 0, "09000064b91e017e"], ["FDA-2007-D-0369-2477", "FDA", "FDA-2007-D-0369", "PSG_204017 - Draft Guidance on Ethinyl Estradiol; Levonorgestrel", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:35:51Z", null, 1, 0, "09000064b91e014e"], ["FDA-2007-D-0369-2496", "FDA", "FDA-2007-D-0369", "PSG_213004 - Draft Guidance on Amoxicillin; Omeprazole Magnesium; Rifabutin", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:41:55Z", null, 1, 0, "09000064b91e0188"], ["FDA-2007-D-0369-2434", "FDA", "FDA-2007-D-0369", "PSG_018859 - Draft Guidance on Ribavirin", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:19:33Z", null, 1, 0, "09000064b91df4c8"], ["FDA-2007-D-0369-2431", "FDA", "FDA-2007-D-0369", "PSG_017874 - Draft Guidance on Scopolamine", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:18:30Z", null, 1, 0, "09000064b91df463"], ["FDA-2007-D-0369-2449", "FDA", "FDA-2007-D-0369", "PSG_020538 - Draft Guidance on Estradiol", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:24:10Z", null, 1, 0, "09000064b91df4f6"], ["FDA-2007-D-0369-2462", "FDA", "FDA-2007-D-0369", "PSG_021588 - Draft Guidance on Imatinib Mesylate", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:29:47Z", null, 1, 0, "09000064b91e0125"], ["FDA-2007-D-0369-2513", "FDA", "FDA-2007-D-0369", "PSG_216675 - Draft Guidance on Perfluorohexyloctane", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:47:39Z", null, 1, 0, "09000064b91e01b8"], ["FDA-2007-D-0369-2510", "FDA", "FDA-2007-D-0369", "PSG_216318 - Draft Guidance on Testosterone Cypionate", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:46:43Z", null, 1, 0, "09000064b91e01b1"], ["FDA-2007-D-0369-2458", "FDA", "FDA-2007-D-0369", "PSG_021351 - Draft Guidance on Oxybutynin", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:27:00Z", null, 1, 0, "09000064b91e011d"], ["FDA-2007-D-0369-2436", "FDA", "FDA-2007-D-0369", "PSG_019081 - Draft Guidance on Estradiol", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:20:10Z", null, 1, 0, "09000064b91df4cc"], ["FDA-2007-D-0369-2455", "FDA", "FDA-2007-D-0369", "PSG_021258 - Draft Guidance on Estradiol; Levonorgestrel", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:25:50Z", null, 1, 0, "09000064b91e010c"], ["FDA-2007-D-0369-2451", "FDA", "FDA-2007-D-0369", "PSG_020831 - Draft Guidance on Formoterol Fumarate", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:24:44Z", null, 1, 0, "09000064b91e0104"], ["FDA-2007-D-0369-2450", "FDA", "FDA-2007-D-0369", "PSG_020612 - Draft Guidance on Lidocaine", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:24:27Z", null, 1, 0, "09000064b91df4f8"], ["FDA-2007-D-0369-2430", "FDA", "FDA-2007-D-0369", "PSG_017628 - Draft Guidance on Tolmetin Sodium", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:18:11Z", null, 1, 0, "09000064b91df461"], ["FDA-2007-D-0369-2478", "FDA", "FDA-2007-D-0369", "PSG_205395 - Draft Guidance on Cobicistat; Darunavir Ethanolate", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:36:14Z", null, 1, 0, "09000064b91e0150"], ["FDA-2007-D-0369-2465", "FDA", "FDA-2007-D-0369", "PSG_021986 - Draft Guidance on Dasatinib", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:31:13Z", null, 1, 0, "09000064b91e012b"], ["FDA-2007-D-0369-2483", "FDA", "FDA-2007-D-0369", "PSG_208036 - Draft Guidance on Barium Sulfate", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:37:51Z", null, 1, 0, "09000064b91e015a"], ["FDA-2007-D-0369-2468", "FDA", "FDA-2007-D-0369", "PSG_022198 - Draft Guidance on Granisetron", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:32:47Z", null, 1, 0, "09000064b91e0131"], ["FDA-2007-D-0369-2470", "FDA", "FDA-2007-D-0369", "PSG_022395 - Draft Guidance on Capsaicin", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:33:25Z", null, 1, 0, "09000064b91e0135"], ["FDA-2007-D-0369-2505", "FDA", "FDA-2007-D-0369", "PSG_215352 - Draft Guidance on Phenylephrine Hydrochloride; Tropicamide", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:45:07Z", null, 1, 0, "09000064b91e019a"], ["FDA-2007-D-0369-2518", "FDA", "FDA-2007-D-0369", "PSG_217514 - Draft Guidance on Dabrafenib Mesylate", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:49:32Z", null, 1, 0, "09000064b91e01cf"], ["FDA-2007-D-0369-2487", "FDA", "FDA-2007-D-0369", "PSG_210136 - Draft Guidance on Buprenorphine", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:39:03Z", null, 1, 0, "09000064b91e016c"], ["FDA-2007-D-0369-2502", "FDA", "FDA-2007-D-0369", "PSG_214826 - Draft Guidance on Lorazepam", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:44:20Z", null, 1, 0, "09000064b91e0194"], ["FDA-2007-D-0369-2504", "FDA", "FDA-2007-D-0369", "PSG_215110 - Draft Guidance on Glecaprevir; Pibrentasvir", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:44:51Z", null, 1, 0, "09000064b91e0198"], ["FDA-2007-D-0369-2474", "FDA", "FDA-2007-D-0369", "PSG_202155 - Draft Guidance on Apixaban", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:34:51Z", null, 1, 0, "09000064b91e013e"], ["FDA-2007-D-0369-2499", "FDA", "FDA-2007-D-0369", "PSG_214187 - Draft Guidance on Sofosbuvir; Velpatasvir", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:43:04Z", null, 1, 0, "09000064b91e018e"], ["FDA-2007-D-0369-2471", "FDA", "FDA-2007-D-0369", "PSG_022549 - Draft Guidance on Loxapine", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:33:45Z", null, 1, 0, "09000064b91e0138"], ["FDA-2007-D-0369-2463", "FDA", "FDA-2007-D-0369", "PSG_021590 - Draft Guidance on Clozapine", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:30:34Z", null, 1, 0, "09000064b91e0127"], ["FDA-2007-D-0369-2452", "FDA", "FDA-2007-D-0369", "PSG_020870 - Draft Guidance on Estradiol; Norethindrone Acetate", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:25:03Z", null, 1, 0, "09000064b91e0106"], ["FDA-2007-D-0369-2445", "FDA", "FDA-2007-D-0369", "PSG_020310 - Draft Guidance on Ketoconazole", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:22:59Z", null, 1, 0, "09000064b91df4ee"], ["FDA-2007-D-0369-2433", "FDA", "FDA-2007-D-0369", "PSG_018731 - Draft Guidance on Buspirone Hydrochloride", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:19:11Z", null, 1, 0, "09000064b91df467"], ["FDA-2007-D-0369-2437", "FDA", "FDA-2007-D-0369", "PSG_019758 - Draft Guidance on Clozapine", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:20:28Z", null, 1, 0, "09000064b91df4ce"], ["FDA-2007-D-0369-2526", "FDA", "FDA-2007-D-0369", "PSG_220073 - Draft Guidance on Apixaban", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:52:29Z", null, 1, 0, "09000064b91e01f3"], ["FDA-2007-D-0369-2519", "FDA", "FDA-2007-D-0369", "PSG_218316 - Draft Guidance on Semaglutide", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:49:49Z", null, 1, 0, "09000064b91e01d1"], ["FDA-2007-D-0369-2521", "FDA", "FDA-2007-D-0369", "PSG_218550 - Draft Guidance on Entrectinib", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:50:35Z", null, 1, 0, "09000064b91e01d5"], ["FDA-2007-D-0369-2524", "FDA", "FDA-2007-D-0369", "PSG_219097 - Draft Guidance on Imatinib Mesylate", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:51:42Z", null, 1, 0, "09000064b91e01db"], ["FDA-2007-D-0369-2525", "FDA", "FDA-2007-D-0369", "PSG_219104 - Draft Guidance on Letermovir", "Other", "Guidance", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-04-29T03:59:59Z", "2026-02-27T19:52:13Z", null, 1, 0, "09000064b91e01dd"]], "truncated": false, "filtered_table_rows_count": 99, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA-2007-D-0369", "p1": "2026"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2026", "results": [{"value": "FDA", "label": "FDA", "count": 99, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2026&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2026", "results": [{"value": "Other", "label": "Other", "count": 98, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2026&document_type=Other", "selected": false}, {"value": "Notice", "label": "Notice", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2026&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2026", "results": [{"value": 2026, "label": 2026, "count": 99, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2026&_facet=subtype"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2026&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2026&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2026&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2026&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2026&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 621.829821029678, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}